Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Collaboration to combine Korro's RNA editing technology and Genevant's LNP technology Korro Bio, a leading RNA editing company focused on the discovery and development of novel genetic medicines
Morgan Stanley favored Moderna (MRNA) Tuesday, noting the U.S. government backed the company in a patent lawsuit against Arbutus Biopharma (ABUS) and Genevant. Read the full story here.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
The U.S. government is asserting that it, not Moderna, should face a lawsuit that alleges the company committed ...
As the government’s Covid-19 response winds down, the Biden administration is mulling a plan to keep vaccines, tests and treatments free<b> </b>for the uninsured into 2024.